A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer

John F.R. Robertson; Zefei Jiang; Angelo Di Leo; Shinji Ohno; Kathleen I. Pritchard; Matthew Ellis; Ian Bradbury; Christine Campbell

doi:10.1007/s12282-019-00973-4

A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer

John F.R. Robertson, Zefei Jiang, Angelo Di Leo, Shinji Ohno, Kathleen I. Pritchard, Matthew Ellis, Ian Bradbury, Christine Campbell

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	703-711
Number of pages	9
Journal	Breast Cancer
Volume	26
Issue number	6
DOIs	https://doi.org/10.1007/s12282-019-00973-4
Publication status	Published - Nov 1 2019
Externally published	Yes

ASJC Scopus Subject Areas

Oncology
Radiology Nuclear Medicine and imaging
Pharmacology (medical)

Keywords

Advanced breast cancer
Clinical benefit rate
Fulvestrant
Hormone receptor-positive
Meta-analysis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s12282-019-00973-4

Cite this

@article{2fc17bf9786e4c20b6d97755726c1590,

title = "A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer",

keywords = "Advanced breast cancer, Clinical benefit rate, Fulvestrant, Hormone receptor-positive, Meta-analysis",

author = "Robertson, {John F.R.} and Zefei Jiang and {Di Leo}, Angelo and Shinji Ohno and Pritchard, {Kathleen I.} and Matthew Ellis and Ian Bradbury and Christine Campbell",

note = "Publisher Copyright: {\textcopyright} 2019, The Author(s).",

year = "2019",

month = nov,

day = "1",

doi = "10.1007/s12282-019-00973-4",

language = "English",

volume = "26",

pages = "703--711",

journal = "Breast Cancer",

issn = "1340-6868",

publisher = "Springer Japan",

number = "6",

}

TY - JOUR

T1 - A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer

AU - Robertson, John F.R.

AU - Jiang, Zefei

AU - Di Leo, Angelo

AU - Ohno, Shinji

AU - Pritchard, Kathleen I.

AU - Ellis, Matthew

AU - Bradbury, Ian

AU - Campbell, Christine

PY - 2019/11/1

Y1 - 2019/11/1

KW - Advanced breast cancer

KW - Clinical benefit rate

KW - Fulvestrant

KW - Hormone receptor-positive

KW - Meta-analysis

UR - http://www.scopus.com/inward/record.url?scp=85065740802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065740802&partnerID=8YFLogxK

U2 - 10.1007/s12282-019-00973-4

DO - 10.1007/s12282-019-00973-4

M3 - Article

C2 - 31079343

AN - SCOPUS:85065740802

SN - 1340-6868

VL - 26

SP - 703

EP - 711

JO - Breast Cancer

JF - Breast Cancer

IS - 6

ER -